“…We evaluated the effects of COVID-19 vaccination (BioNTech Pfizer, Moderna, AstraZeneca) on standard coagulation parameters, whole blood coagulation (Thrombelastometry), platelet function (impedance aggregation), and thrombin generation (calibrated automated thrombography) in people with type 1 diabetes mellitus (n = 41) and type 2 diabetes mellitus (n = 37). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This study includes vaccines from Pfizer-BioNTech, Oxford-AstraZeneca, Sinopharm, and Moderna. The COVID-19 vaccine-related adverse events were classified into three types: local side effects, systemic side effects, and other side effects such as allergies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Two adenoviral vector vaccines, ChAdOx1 nCov-19 (AstraZeneca) and Ad26.COV2.S (Johnson&Johnson/Janssen) have shown to be effective and they are distributed globally, but reports on serious cerebral venous sinus thrombosis (CVST) associated with thrombocytopenia, have emerged. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Specifically, two viral vector-based vaccines [Vaxzervria(®) (AstraZeneca; AZD1222) and COVID-19 Janssen(®) vaccine (Johnson & Johnson; Ad26.COV2. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…DISCLOSURES: Florian Wagenlehner, MD, Achaogen: Advisory Board member, study participation|Astellas: Honoraria|AstraZeneca: Honoraria|AstraZeneca: Advisory Board member|Biomedical Advanced Research and Development Authority (BARDA): Grant/Research Support|Bionorica: Honoraria|Bionorica: Meeting/travel support, study participation|Deutsches Zentrum für Infektionsforschung (DZIF): Study participation|Enteris BioPharma: Study participation|Everest Medicines: Grant/Research Support|German S3 guideline Urinary tract infections: Board Member|Glaxo Smith Kline: Advisor/Consultant|Glaxo Smith Kline: Honoraria|Glaxo Smith Kline: Consulting fees, meeting/travel support, advisory board member, principal investigator in a GSK-sponsored study|Global Antibiotic Research and Development Partnership (GARDP Foundation): Grant/Research Support|Guidelines European Association of Urology: Infections in Urology: Board Member|Helperby Therapeutics: Study participation|Janssen: Honoraria|Janssen: Advisory Board member|Klosterfrau: Honoraria|LeoPharma: Advisory Board member|MerLion: Advisory Board member|MIP Pharma: Honoraria|MSD: Advisory Board member|OM Pharma/Vifor Pharma: Advisory Board member, study participation|OM-Pharma: Honoraria|Pfizer: Honoraria|Pfizer: Advisory Board member|RosenPharma: Advisory Board member|Shionogi: Advisory Board member, study participation|Speaker research group German research foundation (DFG) Bacterial Renal Infections and Defense (FOR 5427): Study participation|Spero Therapeutics: Advisor/Consultant|Spero Therapeutics: Consulting fees|University Hospital Giessen and Marburg GmbH, and Justus Liebig University, Germany: Employee|Venatorx Pharmaceuticals, Inc.: Advisor/Consultant|Venatorx Pharmaceuticals, Inc.: Grant/Research Support|Venatorx Pharmaceuticals, Inc.: Consulting fees, Advisory Board member Caroline R. …”
Enlace del recurso
Enlace del recurso

“…Englund, MD, AstraZeneca (Scientific Research Study Investigator)GSK group of companies (Scientific Research Study Investigator)Meissa vaccines (Consultant)Merck (Scientific Research Study Investigator)Sanofi Pasteur (Consultant) Sanjay Gandhi, MD, GSK group of companies (Employee) Mélanie Hercor, PhD, GSK group of companies (Employee) Magali de Heusch, PhD, GSK group of companies (Employee) Joanne M. …”
Enlace del recurso
Enlace del recurso

“…Sur les 190 patients (84,4 %) vaccinés, Pfizer/BioNTech (n = 157, 82,6 %) et l’Astra Zeneca (n = 22, 11,5 %) étaient les vaccins les plus courants ; 11 patients (5,8 %) avaient reçu Moderna. …”
Enlace del recurso
Enlace del recurso

“…Otero:  ASTRA ZENECA: Current Employment. Abello:  Dr Reddy's: Research Funding; Amgen: Honoraria; Janssen: Honoraria. …”
Enlace del recurso
Enlace del recurso

“…METHOD: Individuals with IBD from a prospective cohort in Calgary, Canada (n=670) who received a 1(st), 2(nd), 3(rd), and/or 4(th) dose of a SARS-CoV-2 vaccine (Pfizer-BioNTech, Moderna, and/or AstraZeneca) were interviewed via telephone for AEs using the Adverse Events Following Immunization form. …”
Enlace del recurso
Enlace del recurso

“…Pinilla Ibarz:  AbbVie, Janssen, AstraZeneca, Novartis, TG Therapeutics, Takeda: Consultancy, Other: Advisory; Sellas: Other: ), patents/royalties/other intellectual property; MEI, Sunesis: Research Funding; AbbVie, Janssen, AstraZeneca, Takeda: Speakers Bureau. …”
Enlace del recurso
Enlace del recurso

“…Patient: Male, 18-year-old Final Diagnosis: Thrombosis with thrombocytopenia syndrome • probable vaccine-induced immune thrombotic thrombocytopenia Symptoms: Headache • hemiparesis • intracranial hemorrhage • thrombocytopenia • vomiting Clinical Procedure: Decompressive craniotomy • exploratory laparotomy • small bowel anastomosis • IVIG administration Specialty: Surgery OBJECTIVE: Unusual clinical course BACKGROUND: Thrombosis with thrombocytopenia syndrome (TTS), including vaccine-induced immune thrombotic thrombocytopenia (VITT), is an extremely rare adverse effect, mostly seen after initial vaccination with the viral vector-based AstraZeneca-Oxford COVID-19 vaccine. It is characterized by mild to severe thrombocytopenia and venous or arterial thrombosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A total of 1150 participants who received one of the COVID-19 vaccines, for instance, Sinopharm, AstraZeneca, Sinovac, and Pfizer (double or booster doses) were included in the study and allocated into two groups: diabetics (n=540) and non-diabetics (n=610). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Significant differences were observed in the titer of anti-S antibodies produced after a first dose of the vaccines ChAdOx1 nCov-19/AstraZeneca, mRNA-1273/Moderna, BNT162b2/Pfizer-BioNTech, and Ad26.COV.S/Janssen. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Case series Patients: Female, 65-year-old • Male, 49-year-old Final Diagnosis: Ad26.COV2-S vaccine-induced thrombotic thrombocytopenia • end stage renal disease Symptoms: ESKD • kidney infarct • pulmonary embolism • thrombocytopenia • thrombosis Clinical Procedure: Kidney transplantation Specialty: Hematology • Immunology • Transplantology • Urology OBJECTIVE: Rare disease BACKGROUND: Vaccine-induced thrombosis and thrombocytopenia is a rare immune disorder documented after adenoviral vector ChAdOx1 nCOV-19 (AstraZeneca) and Ad26.COV2-S (Janssen) vaccine administration against severe acute respiratory syndrome coronavirus 2. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…FUNDING: This study is conducted by the Observational & Pragmatic Research International Ltd and was co-funded by Optimum Patient Care and AstraZeneca. No funding was received by the Observational & Pragmatic Research Institute Pte Ltd (OPRI) for its contribution.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The majority of events were with the AstraZeneca vaccine and with the first dose. Of these, 74.8% were venous thromboembolic events, 12.7% were arterial thromboembolic events, and the rest were hemorrhagic complications. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Most of the study patients had been previously exposure to SARS CoV-2 (113/300) and 66.7% (34/51) of AstraZeneca vaccinated patients had no antibody. CONCLUSION: Due to the synergy of symptoms, screening for COVID-19 in patients presenting with malaria-like symptoms is vital for immediate diagnosis and treatment.…”
Enlace del recurso
Enlace del recurso

“…The first authorised vaccines were the Pfizer-BioNTech mRNA (BNT162b2) and the Oxford-AstraZeneca adenovirus vectored (ChAdOx1 nCoV-19) vaccines. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This systematic review reports 29 cases of GBS following COVID‐19 vaccination, particularly those following the AstraZeneca/Oxford vaccine. Further research is needed to assess all COVID‐19 vaccines' side effects, including GBS.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso